Company / Book Value per Share
X4 Pharmaceuticals, Inc Book Value per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$3.887
FY2025
5-year range
-$4.779 / $7.925
FY2021-FY2025
Trend
+778.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Book Value per Share changed +779% YoY in FY2025, a notable deviation from the 5-year average annual change of +175%.
Based on SEC 10-K filings.
$3.887 in FY2025 with a 3-year CAGR of +14.5%.
Improved from $2.588 to $3.887 over the past 3 years.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- +14.5%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of +14.5%, indicating consistent growth.
- In FY2025, book value per share increased 778.9% year-over-year.
- Peak book value per share was recorded in FY2021.
- Lowest book value per share in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score -0.53 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.887 | +778.9% |
| FY2024 | $0.442 | -82.9% |
| FY2022 | $2.588 | -67.3% |
| FY2021 | $7.925 | +265.8% |
| FY2020 | -$4.779 | -20.8% |
| FY2018 | -$3.957 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026